Veracyte Inc (VCYT)

Apr 25, 2026

Veracyte (VCYT) down 15.4% since last earnings report: Can it rebound? - MSN

Apr 25, 2026

Apr 25, 2026

Q3 2025 Veracyte Inc Earnings Call Transcript - GuruFocus

Apr 25, 2026

Apr 25, 2026

Q1 2025 Veracyte Inc Earnings Call Transcript - GuruFocus

Apr 25, 2026

Apr 25, 2026

Q2 2025 Veracyte Inc Earnings Call Transcript - GuruFocus

Apr 25, 2026

Apr 25, 2026

Veracyte Inc at Piper Sandler Healthcare Conference (Virtual)Pre-recorded Fireside Chat Transcript - GuruFocus

Apr 25, 2026

Apr 24, 2026

Veracyte Inc (VCYT) Stock Up 3.5% and Still Undervalued -- GF Sc - GuruFocus

Apr 24, 2026

Apr 24, 2026

Emerging Sub-Segments Transforming the Thyroid Cancer Diagnostics Market Landscape - openPR.com

Apr 24, 2026

Apr 22, 2026

VCYT Veracyte delivers triple digit Q4 2025 EPS beat and 16 percent annual revenue growth despite mild stock dip.EBITDA Margin - Cổng thông tin điện tử Tỉnh Sơn La

Apr 22, 2026

Apr 22, 2026

Veracyte (NASDAQ: VCYT) asks investors to back directors, auditor and larger equity plan - Stock Titan

Apr 22, 2026

Apr 21, 2026

Emerging Growth Patterns Driving Expansion in the Liquid Biopsy for Cancer Diagnostics Market - openPR.com

Apr 21, 2026

Apr 20, 2026

VCYT Maintained by Canaccord Genuity -- Price Target Lowered to $40 - GuruFocus

Apr 20, 2026

Apr 20, 2026

CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Cuts Target Price to $40 - Moomoo

Apr 20, 2026

Apr 20, 2026

Veracyte Price Target Cut to $40.00/Share From $43.00 by Canaccord Genuity - Moomoo

Apr 20, 2026

Apr 20, 2026

Veracyte (NASDAQ:VCYT) Given New $40.00 Price Target at Canaccord Genuity Group - MarketBeat

Apr 20, 2026

Apr 19, 2026

Is Veracyte (VCYT) Offering Value After Mixed Returns And Conflicting Valuation Signals - Yahoo Finance

Apr 19, 2026

Apr 19, 2026

Veracyte, Inc. (NASDAQ:VCYT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Apr 19, 2026

Apr 16, 2026

Assessing Veracyte (VCYT) Valuation After A Recent Share Price Rebound - Sahm

Apr 16, 2026

Apr 16, 2026

Sumitomo Mitsui Trust Group Inc. Sells 224,185 Shares of Veracyte, Inc. $VCYT - MarketBeat

Apr 16, 2026

Apr 15, 2026

Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026 - BioSpace

Apr 15, 2026

Apr 14, 2026

Veracyte to Release Q1 2026 Results on May 5 - National Today

Apr 14, 2026

Apr 14, 2026

Veracyte to Release Q1 2026 Earnings on May 5 - National Today

Apr 14, 2026

Apr 14, 2026

Veracyte (NASDAQ: VCYT) awards 44,221 RSUs to Chief Dev and Tech Officer - Stock Titan

Apr 14, 2026

Apr 14, 2026

Jefferies Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $45 - 富途牛牛

Apr 14, 2026

Apr 14, 2026

Veracyte Inc (VCYT) Stock Up 4.3% and Still Undervalued -- GF Sc - GuruFocus

Apr 14, 2026

Apr 14, 2026

Jefferies initiates coverage of Veracyte (VCYT) with buy recommendation - MSN

Apr 14, 2026

Apr 13, 2026

VCYT Initiates Coverage by Jefferies -- Price Target Set at $45 - GuruFocus

Apr 13, 2026

Apr 13, 2026

Veracyte (NASDAQ:VCYT) Coverage Initiated at Jefferies Financial Group - MarketBeat

Apr 13, 2026

Apr 13, 2026

Jefferies Initiates Veracyte at Buy With $45 Price Target - marketscreener.com

Apr 13, 2026

Apr 13, 2026

Jefferies initiates Veracyte stock with buy on diagnostics growth - Investing.com UK

Apr 13, 2026

Apr 13, 2026

Jefferies initiates Veracyte stock with buy on diagnostics growth By Investing.com - Investing.com Canada

Apr 13, 2026

Apr 12, 2026

Veracyte | 4: Statement of changes in beneficial ownership of securities-Officer Wygant Jonathan - Moomoo

Apr 12, 2026

Apr 11, 2026

VCYT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 11, 2026

Apr 10, 2026

Sentiment Watch: Can Veracyte Inc be the next market leaderPortfolio Gains Report & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Veracyte Inc (VCYT) Shares Down 4.29% on Apr 9 - GuruFocus

Apr 09, 2026

Apr 09, 2026

Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Apr 09, 2026

Apr 09, 2026

Veracyte Stock Crosses Below 200-Day Moving Average - National Today

Apr 09, 2026

Apr 09, 2026

Veracyte (NASDAQ:VCYT) Stock Price Crosses Below 200 Day Moving AverageHere's Why - MarketBeat

Apr 09, 2026

Apr 04, 2026

Veracyte, Inc. (VCYT) Stock forecasts - Yahoo Finance UK

Apr 04, 2026

Apr 04, 2026

VCYT Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 04, 2026

VCYT PE Ratio & Valuation, Is VCYT Overvalued - Intellectia AI

Apr 04, 2026

Apr 02, 2026

Veracyte Inc (NASDAQ:VCYT) Emerges as a Prime Growth at a Reasonable Price (GARP) Candidate - ChartMill

Apr 02, 2026

Apr 02, 2026

Emerging Growth Patterns Driving Rapid Expansion in the Oncology Molecular Diagnostics Market - openPR.com

Apr 02, 2026

Apr 02, 2026

Precision Trading with Veracyte Inc. (VCYT) Risk Zones - Stock Traders Daily

Apr 02, 2026

Apr 01, 2026

Veracyte (VCYT): Needham Reaffirms "Buy" Rating with $48 Price T - GuruFocus

Apr 01, 2026

Apr 01, 2026

Veracyte (NASDAQ:VCYT) Given "Buy" Rating at Needham & Company LLC - MarketBeat

Apr 01, 2026

Apr 01, 2026

Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $48 - Moomoo

Apr 01, 2026

Apr 01, 2026

Needham reiterates Veracyte stock rating on bladder cancer test plans By Investing.com - Investing.com South Africa

Apr 01, 2026

Apr 01, 2026

Needham reiterates Veracyte stock rating on bladder cancer test plans - Investing.com

Apr 01, 2026

Apr 01, 2026

Veracyte, Inc. (VCYT) stock price, news, quote and history - uk.finance.yahoo.com

Apr 01, 2026